Definitive Contract 75N93021C00040
Ended Awarded Last action
- Contract number
- 75N93021C00040
- Awardee
-
Avantgen Inc. UEI WLNHKNPNT2M7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $356,021
Award facts
- Opportunity
-
- PHS202101 Solicitation number
- Contract value 100% obligated
- $356,021.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 10 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $356,021 |
About this award
This is a $356,021 firm-fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Avantgen Inc., a San Diego-based biotechnology company. The contract is for the development of rabbit monoclonal antibodies for ferret biomarkers. This work is set aside for small businesses. Avantgen has previously received NIH contracts to develop rapid diagnostic tests for infectious diseases like COVID-19 and hepatitis C, as well as monoclonal antibodies for cancer immunotherapy. The current contract supports Avantgen's continued work in the development of therapeutic and diagnostic products and services, particularly in the area of infectious disease research and detection.
Quick answers
Who was awarded contract 75N93021C00040?
75N93021C00040 was awarded to Avantgen Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2021.
How much is contract 75N93021C00040 worth?
The government has obligated $356,021 on 75N93021C00040.
Was contract 75N93021C00040 competed?
The extent of competition for 75N93021C00040 was full and open competition after exclusion of sources. The government received 10 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award